HeartLung AI

HeartLung.AI is a health-tech company aiming to bring AI-enabled early detection and prevention of cardiovascular disease and lung cancer to mass adoption. HeartLung cleared FDA 510(k) for AutoBMD which is the only DEXA-equivalent, CT-based opportunistic osteoporosis screening approved by FDA that is applicable to 25+ million CT scans every year. HeartLung.AI received FDA "Breakthrough Designation" for AutoChamber AI that detects enlarged cardiac chambers and left ventricular hypertrophy in non-contrast chest CT scans which are invisible to human eyes. HeartLung is awaiting approval for AutoCAC (Automated Coronary Calcium Scoring) and several other AI modules focusing on chest CT scans. For more information, visit www.heartlung.ai or email [email protected].